REQUEST A DEMO
Total
USD $0.00
Search more companies

Genolution Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Genolution Inc. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a company principally engaged in the manufacture and distribution of molecular diagnostic equipment and products related ribonucleic acid interference (RNAi) research. The Company's products include automated nucleic acid extraction devices, nucleic acid extraction reagents and molecular diagnostic products. The Company also provides ribonucleic acid interference services. The Company distributes its products within domestic market and to overseas markets. The Company was founded on February 20, 2006. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on August 3, 2015.

Headquarters
11Th Floor, Asan Institute For Life Sciences. 88, Olympic-Ro 43-Gil, Songpa-Gu
Seoul; Seoul; Postal Code: 138-736

Contact Details: Purchase the Genolution Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Genolution Inc. report to view the information.
Outstanding Shares:
Purchase the Genolution Inc. report to view the information.
Registered Capital:
Purchase the Genolution Inc. report to view the information.
Financial Auditors:
Purchase the Genolution Inc. report to view the information.
Incorporation Date:
February 20, 2006
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
40.5%
Purchase this report to view the information.
15.9%
Purchase this report to view the information.
9.5%
Subsidiaries
Ek Health Services Inc
주식회사 진엑스
주식회사 호일바이오메드
Company Performance
Financial values in the chart are available after Genolution Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-59.41%
Total operating revenue
-56%
Operating profit (EBIT)
-377.9%
EBITDA
-3098.78%
Net Profit (Loss) for the Period
N/A
Total assets
-0.09%
Total equity
-10.18%
Operating Profit Margin (ROS)
-141.68%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
12.16%
Quick Ratio
-26.72%
Cash Ratio
-3.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?